American Express Co. buy BiotechBee
Start price
17.09.23
/
70%
€153.05
Target price
31.01.26
€200.00
Performance (%)
3.92%
End price
02.12.23
€159.05
Summary
This prediction ended on 02.12.23 with a price of €159.05. The BUY prediction by BiotechBee finished with a performance of 3.92%. A total of €0.57 was paid as dividends for this prediction. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| American Express Co. | 1.638% | 1.638% | 11.192% |
| iShares Core DAX® | 2,59 % | 2,69 % | 6,41 % |
| iShares Nasdaq 100 | -0,91 % | -7,37 % | 20,65 % |
| iShares Nikkei 225® | 0,15 % | -10,20 % | 46,17 % |
| iShares S&P 500 | -0,37 % | -0,83 % | 18,02 % |
According to BiotechBee what are the pros and cons of American Express Co. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread American Express Co. diskutieren
Buy mit Kursziel 200,0